This information was published on 2024-07-24T00:05:08 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2454189 (IR 1791369) |
| (220) |
18 Mar 2024
|
| (300) |
US, 23 Feb 2024, 98418502
|
| (511) (510) |
Class 5
Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders. |
| (540) | SHOXORBA |
| (550) | Word |
| (730) |
Bridgebio Pharma, Inc.
|
Find out more about publications on the About page.